High-risk group |
|
|
|
KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS |
25 |
1.997 |
<0.001 |
KEGG_RNA_POLYMERASE |
29 |
1.849 |
0.008 |
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS |
41 |
1.848 |
0.008 |
KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM |
16 |
1.726 |
0.014 |
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS |
11 |
1.611 |
0.03 |
KEGG_LYSINE_DEGRADATION |
44 |
1.526 |
0.05 |
Low-risk group |
|
|
|
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION |
258 |
-2.777 |
<0.001 |
KEGG_CHEMOKINE_SIGNALING_PATHWAY |
186 |
-2.765 |
<0.001 |
KEGG_CELL_ADHESION_MOLECULES_CAMS |
131 |
-2.716 |
<0.001 |
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY |
130 |
-2.694 |
<0.001 |
KEGG_VIRAL_MYOCARDITIS |
68 |
-2.647 |
<0.001 |
KEGG_JAK_STAT_SIGNALING_PATHWAY |
151 |
-2.634 |
<0.001 |
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION |
79 |
-2.578 |
<0.001 |
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION |
116 |
-2.565 |
<0.001 |
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY |
101 |
-2.525 |
<0.001 |
KEGG_LEISHMANIA_INFECTION |
69 |
-2.483 |
<0.001 |
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY |
107 |
-2.478 |
<0.001 |
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS |
131 |
-2.477 |
<0.001 |
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS |
95 |
-2.468 |
<0.001 |
KEGG_HEMATOPOIETIC_CELL_LINEAGE |
85 |
-2.458 |
<0.001 |
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY |
61 |
-2.414 |
<0.001 |
KEGG_AUTOIMMUNE_THYROID_DISEASE |
50 |
-2.39 |
<0.001 |
KEGG_APOPTOSIS |
86 |
-2.34 |
<0.001 |
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY |
74 |
-2.318 |
<0.001 |
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY |
79 |
-2.304 |
<0.001 |